QC
TXG icon

Quent Capital’s 10x Genomics TXG Stock Holding History

Quent Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$194K Buy
9,149
+12
+0.1% +$240 0.01% 391
2025
Q4 		$149K Buy
9,137
+8,840
+2,976% +$134K 0.01% 453
2025
Q3 		$3.47K Buy
+297
New +$3.87K ﹤0.01% 1202
2025
Q2 		– Sell
-395
Closed -$3.45K – 1170
2025
Q1 		$3.45K Buy
395
+387
+4,838% +$4.88K ﹤0.01% 1072
2024
Q4 		$115 Sell
8
-8,908
-100% -$141K ﹤0.01% 1315
2024
Q3 		$201K Hold
8,916
– – 0.02% 333
2024
Q2 		$173K Buy
8,916
+4,068
+84% +$107K 0.02% 335
2024
Q1 		$182K Hold
4,848
– – 0.02% 342
2023
Q4 		$271K Hold
4,848
– – 0.04% 246
2023
Q3 		$200K Buy
4,848
+987
+26% +$51.3K 0.03% 280
2023
Q2 		$216K Hold
3,861
– – 0.03% 265
2023
Q1 		$201K Buy
3,861
+13
+0.3% +$607 0.03% 278
2022
Q4 		$140K Buy
3,848
+8
+0.2% +$262 0.03% 333
2022
Q3 		$109K Sell
3,840
-1,000
-21% -$38.1K 0.02% 359
2022
Q2 		$219K Hold
4,840
– – 0.05% 216
2022
Q1 		$368K Buy
4,840
+4,677
+2,869% +$409K 0.07% 185
2021
Q4 		$24K Buy
+163
New +$25K 0.01% 693

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quent Capital's TXG Position: Q1 2026 in Review

Quent Capital increased its 10x Genomics (TXG) stake by 0.13% in Q1 2026, buying an estimated $240 and bringing the position to 9,149 shares worth $194K. The position accounts for 0.01% of the portfolio, ranked #391.

Quent Capital first reported a position in TXG in Q4 2021 and has held it in 17 quarters since. The position peaked at $368K in Q1 2022. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Quent Capital held 9,149 shares of 10x Genomics worth $194K as of Q1 2026.
  • Quent Capital bought 12 10x Genomics shares in Q1 2026, an estimated $240.
  • 10x Genomics made up 0.01% of Quent Capital's portfolio in Q1 2026, its #391 holding.
  • Quent Capital first reported a position in 10x Genomics in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's 10x Genomics position peaked at $368K in Q1 2022.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.